BioSpace News Archive

The demand within the global non-invasive ventilators market is growing on account of advancements in healthcare treatment and analysis.

Transparency Market Research delivers key insights on the global digital dose inhalers market.

The elimination and inactivation of viruses continues to remain an important field of research in the field of bioprocess safety.

POINT Biopharma Inc. is pleased to announce the formation of its global prostate oncology therapeutic advisory board.

Axonics Modulation Technologies, Inc. announced that it will release financial results for the first quarter of 2020 after the market closes on Tuesday, May 5, 2020.

Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced the appointment of Marc Schegerin, M.D., as chief financial officer and chief operating officer.

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share positive interim data from its ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most common and most aggressive form of primary brain cancer.

ANJESO Is The Only Approved 24-Hour, Intravenous COX-2 Preferential NSAID that Offers Once-Daily Dosing Full Commercial Launch Expected to Commence by June 2020 MALVERN, Pa., April 07, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that ANJESO™ (meloxicam) injection, the only 24-hour, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory drug (NSAID), is now available for ord

Livongo Health, Inc., (Nasdaq: LVGO) today announced a preliminary financial result for the first quarter of fiscal year 2020.

InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its results for the first quarter 2020 before the Nasdaq market opens on Wednesday, May 6, 2020.